Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

Open Access 07-12-2023 | Irritable Bowel Syndrome | Original Article

Hydrogen Sulfide Producers Drive a Diarrhea-Like Phenotype and a Methane Producer Drives a Constipation-Like Phenotype in Animal Models

Authors: Maria J. Villanueva-Millan, Gabriela Leite, Walter Morales, Maritza Sanchez, Gonzalo Parodi, Stacy Weitsman, Shreya Celly, Daniel Cohrs, Huongly Do, Gillian M. Barlow, Ruchi Mathur, Ali Rezaie, Mark Pimentel

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Abstract

Background

We recently demonstrated that diarrhea-predominant irritable bowel syndrome (IBS-D) subjects have higher relative abundance (RA) of hydrogen sulfide (H2S)-producing Fusobacterium and Desulfovibrio species, and constipation-predominant IBS (IBS-C) subjects have higher RA of methanogen Methanobrevibacter smithii.

Aims

In this study, we investigate the effects of increased methanogens or H2S producers on stool phenotypes in rat models.

Methods

Adult Sprague–Dawley rats were fed high-fat diet (HFD) for 60 days to increase M. smithii levels, then gavaged for 10 days with water (controls) or methanogenesis inhibitors. To increase H2S producers, rats were gavaged with F. varium or D. piger. Stool consistency (stool wet weight (SWW)) and gas production were measured. 16S rRNA gene sequencing was performed on stool samples.

Results

In HFD diet-fed rats (N = 30), stool M. smithii levels were increased (P < 0.001) after 52 days, correlating with significantly decreased SWW (P < 0.0001) at 59 days (R = − 0.38, P = 0.037). Small bowel M. smithii levels decreased significantly in lovastatin lactone-treated rats (P < 0.0006), and SWW increased (normalized) in lovastatin hydroxyacid-treated rats (P = 0.0246), vs. controls (N = 10/group). SWW increased significantly in D. piger-gavaged rats (N = 16) on day 10 (P < 0.0001), and in F. varium-gavaged rats (N = 16) at all timepoints, vs. controls, with increased stool H2S production. 16S sequencing revealed stool microbiota alterations in rats gavaged with H2S producers, with higher relative abundance (RA) of other H2S producers, particularly Lachnospiraceae and Bilophila in F. varium-gavaged rats, and Sutterella in D. piger-gavaged rats.

Conclusions

These findings suggest that increased M. smithii levels result in a constipation-like phenotype in a rat model that is partly reversible with methanogenesis inhibitors, whereas gavage with H2S producers D. piger or F. varium results in increased colonization with other H2S producers and diarrhea-like phenotypes. This supports roles for the increased RA of methanogens and H2S producers identified in IBS-C and IBS-D subjects, respectively, in contributing to stool phenotypes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17:473–486.CrossRefPubMed Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17:473–486.CrossRefPubMed
2.
go back to reference Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M et al. Bowel Disorders. Gastroenterology. 2016;150:1393–407.e5.CrossRef Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M et al. Bowel Disorders. Gastroenterology. 2016;150:1393–407.e5.CrossRef
3.
go back to reference Pimentel M, Lembo A. Microbiome and Its Role in Irritable Bowel Syndrome. Dig Dis Sci. 2020;65:829–39. Pimentel M, Lembo A. Microbiome and Its Role in Irritable Bowel Syndrome. Dig Dis Sci. 2020;65:829–39.
4.
go back to reference Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R et al. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. J Acad Nutr Diet. 2020;120:565–586.CrossRefPubMed Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R et al. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. J Acad Nutr Diet. 2020;120:565–586.CrossRefPubMed
5.
go back to reference Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Dig Liver Dis. 2017;49:331–337.CrossRefPubMed Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Dig Liver Dis. 2017;49:331–337.CrossRefPubMed
6.
go back to reference Villanueva-Millan MJ, Leite G, Wang J, et al. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes. Am J Gastroenterol. 2022. Villanueva-Millan MJ, Leite G, Wang J, et al. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes. Am J Gastroenterol. 2022.
7.
go back to reference Pimentel M, Lezcano S. Irritable Bowel Syndrome: Bacterial Overgrowth–What’s Known and What to Do. Curr Treat Options Gastroenterol. 2007;10:328–337.CrossRefPubMed Pimentel M, Lezcano S. Irritable Bowel Syndrome: Bacterial Overgrowth–What’s Known and What to Do. Curr Treat Options Gastroenterol. 2007;10:328–337.CrossRefPubMed
8.
go back to reference Kim G, Deepinder F, Morales W, Hwang L, Weitsman S, Chang C et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci. 2012;57:3213–3218.CrossRefPubMed Kim G, Deepinder F, Morales W, Hwang L, Weitsman S, Chang C et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci. 2012;57:3213–3218.CrossRefPubMed
9.
go back to reference Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut Liver. 2016;10:932–938.CrossRefPubMedPubMedCentral Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut Liver. 2016;10:932–938.CrossRefPubMedPubMedCentral
10.
go back to reference Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115:165–178.CrossRefPubMed Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115:165–178.CrossRefPubMed
11.
go back to reference Algera JP, Colomier E, Melchior C, Hreinsson JP, Midenfjord I, Clevers E et al. Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome. Neurogastroenterol Motil. 2022;11:e14482. Algera JP, Colomier E, Melchior C, Hreinsson JP, Midenfjord I, Clevers E et al. Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome. Neurogastroenterol Motil. 2022;11:e14482.
12.
go back to reference Mathur R, Kim G, Morales W, Sung J, Rooks E, Pokkunuri V et al. Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats. Obesity (Silver Spring). 2013;21:748–754.CrossRefPubMed Mathur R, Kim G, Morales W, Sung J, Rooks E, Pokkunuri V et al. Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats. Obesity (Silver Spring). 2013;21:748–754.CrossRefPubMed
13.
go back to reference Pimentel M, Morales W, Jee SR, Low K, Hwang L, Pokkunuri V et al. Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS. Dig Dis Sci. 2011;56:1962–1966.CrossRefPubMed Pimentel M, Morales W, Jee SR, Low K, Hwang L, Pokkunuri V et al. Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS. Dig Dis Sci. 2011;56:1962–1966.CrossRefPubMed
14.
go back to reference Gottlieb K, Wacher V, Sliman J, Pimentel M. Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther. 2016;43:197–212.CrossRefPubMed Gottlieb K, Wacher V, Sliman J, Pimentel M. Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther. 2016;43:197–212.CrossRefPubMed
15.
go back to reference Muskal SM, Sliman J, Kokai-Kun J, Pimentel M, Wacher V, Gottlieb K. Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. F1000Res. 2016;5:606. Muskal SM, Sliman J, Kokai-Kun J, Pimentel M, Wacher V, Gottlieb K. Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway. F1000Res. 2016;5:606.
17.
go back to reference Dridi B, Henry M, El Khechine A, Raoult D, Drancourt M. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One. 2009;4:e7063.CrossRefPubMedPubMedCentral Dridi B, Henry M, El Khechine A, Raoult D, Drancourt M. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One. 2009;4:e7063.CrossRefPubMedPubMedCentral
18.
go back to reference Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53:982–989.CrossRefPubMed Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53:982–989.CrossRefPubMed
19.
go back to reference Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:e1.CrossRefPubMed Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:e1.CrossRefPubMed
20.
go back to reference Gaci N, Borrel G, Tottey W, O’Toole PW, Brugere JF. Archaea and the human gut: new beginning of an old story. World J Gastroenterol. 2014;20:16062–16078.CrossRefPubMedPubMedCentral Gaci N, Borrel G, Tottey W, O’Toole PW, Brugere JF. Archaea and the human gut: new beginning of an old story. World J Gastroenterol. 2014;20:16062–16078.CrossRefPubMedPubMedCentral
21.
go back to reference Pimentel M, Lin HC, Enayati P, van den Burg B, Lee HR, Chen JH et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1089–G1095.CrossRefPubMed Pimentel M, Lin HC, Enayati P, van den Burg B, Lee HR, Chen JH et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1089–G1095.CrossRefPubMed
22.
go back to reference Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003;48:86–92.CrossRefPubMed Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003;48:86–92.CrossRefPubMed
23.
go back to reference Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56:1612–1618.CrossRefPubMed Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56:1612–1618.CrossRefPubMed
24.
go back to reference Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007;102:837–841.CrossRefPubMed Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007;102:837–841.CrossRefPubMed
25.
go back to reference Hwang L, Low K, Khoshini R, Melmed G, Sahakian A, Makhani M et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci. 2010;55:398–403.CrossRefPubMed Hwang L, Low K, Khoshini R, Melmed G, Sahakian A, Makhani M et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci. 2010;55:398–403.CrossRefPubMed
26.
go back to reference Triantafyllou K, Chang C, Pimentel M. Methanogens, methane and gastrointestinal motility. Journal of neurogastroenterology and motility. 2014;20:31–40.CrossRefPubMed Triantafyllou K, Chang C, Pimentel M. Methanogens, methane and gastrointestinal motility. Journal of neurogastroenterology and motility. 2014;20:31–40.CrossRefPubMed
27.
go back to reference Kim G, Giamarellos EJ, Pyleris E, et al. Methanobrevibacter smithii is found in human duodenum and is associated with altered luminal cytokines. Gastroenterology. 2012;142:S-98. Kim G, Giamarellos EJ, Pyleris E, et al. Methanobrevibacter smithii is found in human duodenum and is associated with altered luminal cytokines. Gastroenterology. 2012;142:S-98.
28.
go back to reference Smith NW, Shorten PR, Altermann EH, Roy NC, McNabb WC. Hydrogen cross-feeders of the human gastrointestinal tract. Gut Microbes. 2019;10:270–288.CrossRefPubMed Smith NW, Shorten PR, Altermann EH, Roy NC, McNabb WC. Hydrogen cross-feeders of the human gastrointestinal tract. Gut Microbes. 2019;10:270–288.CrossRefPubMed
29.
go back to reference Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448.CrossRefPubMedPubMedCentral Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448.CrossRefPubMedPubMedCentral
30.
go back to reference Doujaiji B, Al-Tawfiq JA. Hydrogen sulfide exposure in an adult male. Ann Saudi Med. 2010;30:76–80. Doujaiji B, Al-Tawfiq JA. Hydrogen sulfide exposure in an adult male. Ann Saudi Med. 2010;30:76–80.
31.
go back to reference Zimmermann KK, Spassov SG, Strosing KM, Ihle PM, Engelstaedter H, Hoetzel A et al. Hydrogen Sulfide Exerts Anti-oxidative and Anti-inflammatory Effects in Acute Lung Injury. Inflammation. 2018;41:249–259.CrossRefPubMed Zimmermann KK, Spassov SG, Strosing KM, Ihle PM, Engelstaedter H, Hoetzel A et al. Hydrogen Sulfide Exerts Anti-oxidative and Anti-inflammatory Effects in Acute Lung Injury. Inflammation. 2018;41:249–259.CrossRefPubMed
32.
go back to reference Skovgaard N, Gouliaev A, Aalling M, Simonsen U. The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol. 2011;12:1385–1393.CrossRefPubMed Skovgaard N, Gouliaev A, Aalling M, Simonsen U. The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol. 2011;12:1385–1393.CrossRefPubMed
33.
go back to reference Singer-Englar T, Rezaie A, Gupta K, et al. 182 - Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine. Gastroenterology. 2018;154:S-47. Singer-Englar T, Rezaie A, Gupta K, et al. 182 - Competitive Hydrogen Gas Utilization by Methane- and Hydrogen Sulfide-Producing Microorganisms and Associated Symptoms: Results of a Novel 4-Gas Breath Test Machine. Gastroenterology. 2018;154:S-47.
34.
go back to reference Quan X, Luo H, Liu Y, Xia H, Chen W, Tang Q. Hydrogen sulfide regulates the colonic motility by inhibiting both L-type calcium channels and BKCa channels in smooth muscle cells of rat colon. PLoS One. 2015;10:e0121331.CrossRefPubMedPubMedCentral Quan X, Luo H, Liu Y, Xia H, Chen W, Tang Q. Hydrogen sulfide regulates the colonic motility by inhibiting both L-type calcium channels and BKCa channels in smooth muscle cells of rat colon. PLoS One. 2015;10:e0121331.CrossRefPubMedPubMedCentral
36.
go back to reference Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003;52:79–83.CrossRefPubMedPubMedCentral Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003;52:79–83.CrossRefPubMedPubMedCentral
37.
go back to reference Yukawa T, Ohkusa T, Shibuya T, Tsukinaga S, Mitobe J, Takakura K et al. Nested Culture Method Improves Detection of Fusobacterium from Stool in Patients with Ulcerative Colitis. Japanese Journal of Infectious Diseases. 2013;66:109–114.CrossRefPubMed Yukawa T, Ohkusa T, Shibuya T, Tsukinaga S, Mitobe J, Takakura K et al. Nested Culture Method Improves Detection of Fusobacterium from Stool in Patients with Ulcerative Colitis. Japanese Journal of Infectious Diseases. 2013;66:109–114.CrossRefPubMed
38.
go back to reference Peck SC, Denger K, Burrichter A, Irwin SM, Balskus EP, Schleheck D. A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia. Proc Natl Acad Sci U S A. 2019;116:3171–3176.CrossRefPubMedPubMedCentral Peck SC, Denger K, Burrichter A, Irwin SM, Balskus EP, Schleheck D. A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia. Proc Natl Acad Sci U S A. 2019;116:3171–3176.CrossRefPubMedPubMedCentral
39.
go back to reference Nguyen LH, Cao Y, Hur J, et al. The Sulfur Microbial Diet Is Associated With Increased Risk of Early-Onset Colorectal Cancer Precursors. Gastroenterology. 2021;161:1423–32 e4. Nguyen LH, Cao Y, Hur J, et al. The Sulfur Microbial Diet Is Associated With Increased Risk of Early-Onset Colorectal Cancer Precursors. Gastroenterology. 2021;161:1423–32 e4.
40.
go back to reference Uchiyama J, Akiyama M, Hase K, Kumagai Y, Kim YG. Gut microbiota reinforce host antioxidant capacity via the generation of reactive sulfur species. Cell Rep. 2022;38:110479.CrossRefPubMed Uchiyama J, Akiyama M, Hase K, Kumagai Y, Kim YG. Gut microbiota reinforce host antioxidant capacity via the generation of reactive sulfur species. Cell Rep. 2022;38:110479.CrossRefPubMed
41.
Metadata
Title
Hydrogen Sulfide Producers Drive a Diarrhea-Like Phenotype and a Methane Producer Drives a Constipation-Like Phenotype in Animal Models
Authors
Maria J. Villanueva-Millan
Gabriela Leite
Walter Morales
Maritza Sanchez
Gonzalo Parodi
Stacy Weitsman
Shreya Celly
Daniel Cohrs
Huongly Do
Gillian M. Barlow
Ruchi Mathur
Ali Rezaie
Mark Pimentel
Publication date
07-12-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08197-5

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.